Kwekkeboom DJ - Search Results

1

Quality of life in patients with gastroenteropancreatic tumors treated with [177Lu-DOTA0,Tyr3]octreotate.

Teunissen JJ, Kwekkeboom DJ, Krenning EP. Teunissen JJ, et al. Among authors: kwekkeboom dj. J Clin Oncol. 2004 Jul 1;22(13):2724-9. doi: 10.1200/JCO.2004.10.016. J Clin Oncol. 2004. PMID: 15226340 Clinical Trial.

2

Somatostatin receptor imaging.

Kwekkeboom DJ, Krenning EP. Kwekkeboom DJ, et al. Semin Nucl Med. 2002 Apr;32(2):84-91. doi: 10.1053/snuc.2002.31022. Semin Nucl Med. 2002. PMID: 11965603 Review.

3

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.

De Jong M, Valkema R, Jamar F, Kvols LK, Kwekkeboom DJ, Breeman WA, Bakker WH, Smith C, Pauwels S, Krenning EP. De Jong M, et al. Among authors: kwekkeboom dj. Semin Nucl Med. 2002 Apr;32(2):133-40. doi: 10.1053/snuc.2002.31027. Semin Nucl Med. 2002. PMID: 11965608 Review.

4

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

Kwekkeboom DJ, Mueller-Brand J, Paganelli G, Anthony LB, Pauwels S, Kvols LK, O'dorisio TM, Valkema R, Bodei L, Chinol M, Maecke HR, Krenning EP. Kwekkeboom DJ, et al. J Nucl Med. 2005 Jan;46 Suppl 1:62S-6S. J Nucl Med. 2005. PMID: 15653653 Free article. Review.

5

Molecular imaging as in vivo molecular pathology for gastroenteropancreatic neuroendocrine tumors: implications for follow-up after therapy.

Krenning EP, Valkema R, Kwekkeboom DJ, de Herder WW, van Eijck CH, de Jong M, Pauwels S, Reubi JC. Krenning EP, et al. Among authors: kwekkeboom dj. J Nucl Med. 2005 Jan;46 Suppl 1:76S-82S. J Nucl Med. 2005. PMID: 15653655 Free article.

6

Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.

Valkema R, Pauwels SA, Kvols LK, Kwekkeboom DJ, Jamar F, de Jong M, Barone R, Walrand S, Kooij PP, Bakker WH, Lasher J, Krenning EP. Valkema R, et al. Among authors: kwekkeboom dj. J Nucl Med. 2005 Jan;46 Suppl 1:83S-91S. J Nucl Med. 2005. PMID: 15653656 Free article. Clinical Trial.

7

Peptide receptor radionuclide therapy for non-radioiodine-avid differentiated thyroid carcinoma.

Teunissen JJ, Kwekkeboom DJ, Kooij PP, Bakker WH, Krenning EP. Teunissen JJ, et al. Among authors: kwekkeboom dj. J Nucl Med. 2005 Jan;46 Suppl 1:107S-14S. J Nucl Med. 2005. PMID: 15653659 Free article. Clinical Trial.

8

Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors.

Kwekkeboom DJ, Teunissen JJ, Bakker WH, Kooij PP, de Herder WW, Feelders RA, van Eijck CH, Esser JP, Kam BL, Krenning EP. Kwekkeboom DJ, et al. J Clin Oncol. 2005 Apr 20;23(12):2754-62. doi: 10.1200/JCO.2005.08.066. J Clin Oncol. 2005. PMID: 15837990 Clinical Trial.

9

Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy.

Teunissen JJ, Kwekkeboom DJ, de Jong M, Esser JP, Valkema R, Krenning EP. Teunissen JJ, et al. Among authors: kwekkeboom dj. Best Pract Res Clin Gastroenterol. 2005 Aug;19(4):595-616. doi: 10.1016/j.bpg.2005.04.001. Best Pract Res Clin Gastroenterol. 2005. PMID: 16183530 Review.

10

Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors.

Valkema R, Pauwels S, Kvols LK, Barone R, Jamar F, Bakker WH, Kwekkeboom DJ, Bouterfa H, Krenning EP. Valkema R, et al. Among authors: kwekkeboom dj. Semin Nucl Med. 2006 Apr;36(2):147-56. doi: 10.1053/j.semnuclmed.2006.01.001. Semin Nucl Med. 2006. PMID: 16517236 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters